SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-062850
Filing Date
2024-05-21
Accepted
2024-05-21 16:00:05
Documents
1
Period of Report
2024-05-17

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4625
  Complete submission text file 0000950170-24-062850.txt   6165
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Issuer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1270 AVENUE OF THE AMERICAS 7TH FLOOR NEW YORK NY 10020
Business Address
Wood Steven D (Reporting) CIK: 0002001007 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41827 | Film No.: 24969188